• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.13% Nasdaq Down 0.93%

    Lexicon Pharmaceuticals, Inc. (LXRX)

    -NasdaqGS
    0.90 Down 0.04(4.05%) 4:00PM EST
    |After Hours : 0.90 0.00 (0.00%) 4:38PM EST
    Add to Portfolio
    Prev Close:0.94
    Open:0.92
    Bid:N/A
    Ask:1.38 x 10700
    1y Target Est:2.75
    Beta:1.59
    Earnings Date:Feb 26 - Mar 2 (Est.)
    Day's Range:0.90 - 0.95
    52wk Range:0.80 - 2.00
    Volume:1,110,748
    Avg Vol (3m):2,262,530
    Market Cap:464.48M
    P/E (ttm):N/A
    EPS (ttm):-0.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LXRX

    Comparison

    Symbol% ChgMkt Cap
    LXRXDown 4.05%464.48M
    DGEN 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):174.01
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.21
    Quarterly EPS Est (Dec-14) :-0.03
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-0.14

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for human disease. Its drug development programs include LX4211, an orally-delivered small molecule compound that has completed two Phase II clini... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback